Phibro Animal Health grants 1,547 RSUs to SVP

Escudero Lisa Ann reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Escudero Lisa Ann reported acquisition or exercise transactions in this Form 4 filing.

PHIBRO ANIMAL HEALTH CORP Senior Vice President of Human Resources Lisa Ann Escudero received a grant of 1,547 restricted stock units (RSUs) of Class A Common Stock on 2026-08-06. The RSUs vest in three substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to continued employment. Following this award, Escudero directly holds 3,434 shares (or share-equivalent RSUs) of Class A Common Stock.

Insider Trade Summary

Grant/Award: 1,547 shares

Grant/Award 1 txn

Insider Escudero Lisa Ann

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1, F2	1,547	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 3,434 shares (Direct)

Footnotes (2)

1. F1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
2. F2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.

Key Figures

RSUs Granted: 1,547 RSUs Grant Price: $0.00 per share Holdings After Grant: 3,434 shares +1 more

4 metrics

RSUs Granted 1,547 RSUs Restricted stock units of Class A Common Stock granted on 2026-08-06

Grant Price $0.00 per share Reported transaction price per share for the RSU award

Holdings After Grant 3,434 shares Total Class A Common Stock share-equivalents following the RSU grant

Vesting Schedule 3 installments RSUs vest in substantially equal installments on first three anniversaries of August 1, 2026

Key Terms

restricted stock units, contingent right, Class A Common Stock

3 terms

restricted stock units financial

"The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"each of which represents a contingent right to receive one share of Class A Common Stock."

Class A Common Stock financial

"to receive one share of Class A Common Stock."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity award did PAHC grant to Lisa Ann Escudero on August 6, 2026?

PHIBRO ANIMAL HEALTH CORP granted 1,547 restricted stock units (RSUs) of Class A Common Stock to Senior Vice President of Human Resources Lisa Ann Escudero on 2026-08-06 as part of her compensation.

How do the new RSUs for PAHC executive Lisa Ann Escudero vest?

Escudero’s 1,547 RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, conditioned on her continued employment through each applicable vesting date.

What is the reported holding of PAHC shares by Lisa Ann Escudero after this Form 4?

After the RSU grant, Lisa Ann Escudero is reported to directly hold 3,434 Class A Common Stock shares (or share-equivalent RSUs) of PHIBRO ANIMAL HEALTH CORP, reflecting her updated beneficial ownership position.

Did Lisa Ann Escudero buy or sell any PAHC shares in the market?

No market purchase or sale is reported. The Form 4 shows a grant of 1,547 RSUs at a price of $0.00 per share, reflecting a compensation-related award rather than an open-market trade.

Is the PAHC RSU grant to Lisa Ann Escudero under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not marked, and there is no footnote stating that the 1,547 RSU grant to Lisa Ann Escudero was made pursuant to a 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 04:16 PM Accepted by SEC EDGAR 08/10/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Escudero Lisa Ann

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NEW JERSEY 07666

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	08/06/2026		A		1,547(2)	A	$0	3,434	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.

2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.

Remarks:

Senior Vice President, Human Resources.

	/s/ Judith Weinstein, as Attorney-in-Fact for Lisa Ann Escudero	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)